Clinical Trial Update: Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.

View source ↗

Summary

Clinical trial update indicating ongoing recruitment to study the prevalence of treatment-induced mutations in metastatic estrogen receptor-positive breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Breast Cancer | Status: RECRUITING